Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C1orf146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MRPS30 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | EIF5B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RAB1A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SEMA6D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RGMA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GLUD1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CREB1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SYNJ2BP-COX16 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | TRIM74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |